Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan IDCW-Sweep | Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan NAV Today [0.00], Performance & History

Other Index/ETF Direct

Regular

Direct

1 Year Absolute Returns

0.00%

NAV (₹) on

0.00

1 Day NAV Change

0.00%

Risk Level

Very High Risk

Rating

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan is a Equity mutual fund categorized under Index, offered by Edelweiss Asset Management Ltd.. Launched on 06 Oct 2020, ... Read more

NAV History

Fund Details

Min. SIP Amount

₹100

Inception Date

06 Oct 2020

Min. Lumpsum Amount

₹ 100

Fund Age

5 Yrs

AUM

₹ 188.90 Cr.

Benchmark

Expense Ratio

0.52%

Scheme Type

Open Ended

Exit Load

Nil%

Asset Allocation

AUM

₹ 188.90 Cr

Equity

420.48%

Money Market & Cash

1.27%

Other Assets & Liabilities

178.32%

Sector Holdings

Sectors	Weightage
Pharmaceuticals	52.63%
Foreign Securities	30.48%
Hospitals & Medical Services	16.67%
Treps/Reverse Repo	0.17%
Net Receivables/(Payables)	0.05%

Stock Holdings

Name	Weightage	Value (in Cr.)	Sector
Sun Pharmaceutical Industries Ltd.	10.96%	₹ 20.70	Pharmaceuticals
ELI LILLY & CO	6.85%	₹ 12.93	Others
Apollo Hospitals Enterprise Ltd.	5.71%	₹ 10.79	Hospitals & Medical Services
Max Healthcare Institute Ltd.	5.21%	₹ 9.84	Hospitals & Medical Services
Divi's Laboratories Ltd.	5.14%	₹ 9.71	Pharmaceuticals
Cipla Ltd.	4.84%	₹ 9.14	Pharmaceuticals
Dr. Reddy's Laboratories Ltd.	4.44%	₹ 8.39	Pharmaceuticals
JOHNSON & JOHNSON	4.35%	₹ 8.21	Others
Lupin Ltd.	3.62%	₹ 6.83	Pharmaceuticals
Laurus Labs Ltd.	3.48%	₹ 6.58	Pharmaceuticals
ABBVIE INC	3.16%	₹ 5.98	Others
Torrent Pharmaceuticals Ltd.	3.07%	₹ 5.79	Pharmaceuticals
Fortis Healthcare Ltd.	3.07%	₹ 5.80	Hospitals & Medical Services
Aurobindo Pharma Ltd.	2.70%	₹ 5.10	Pharmaceuticals
MERCK & CO.INC	2.26%	₹ 4.27	Others
NOVARTIS AG	2.04%	₹ 3.85	Others
Glenmark Pharmaceuticals Ltd.	2.03%	₹ 3.84	Pharmaceuticals
Biocon Ltd.	1.77%	₹ 3.35	Pharmaceuticals
Mankind Pharma Ltd.	1.72%	₹ 3.24	Pharmaceuticals
IPCA Laboratories Ltd.	1.55%	₹ 2.93	Pharmaceuticals
Alkem Laboratories Ltd.	1.52%	₹ 2.88	Pharmaceuticals
AMGEN INC	1.39%	₹ 2.62	Others
Zydus Lifesciences Ltd.	1.35%	₹ 2.56	Pharmaceuticals
THERMO FISHER SCIENTIFIC INC	1.33%	₹ 2.50	Others
JB Chemicals & Pharmaceuticals Ltd.	1.21%	₹ 2.28	Pharmaceuticals
Gland Pharma Ltd.	1.21%	₹ 2.28	Pharmaceuticals
Aster DM Healthcare Ltd.	1.20%	₹ 2.26	Hospitals & Medical Services
ABBOTT LABORATORIES	1.12%	₹ 2.12	Others
GILEAD SCIENCES INC	1.11%	₹ 2.11	Others
Novo Nordisk A/S	1.10%	₹ 2.07	Others
INTUITIVE SURGICAL INC	1.00%	₹ 1.90	Others
Ajanta Pharma Ltd.	0.98%	₹ 1.85	Pharmaceuticals
VERTEX PHARMACEUTICALS INC	0.90%	₹ 1.70	Others
DANAHER CORP	0.86%	₹ 1.63	Others
Narayana Hrudayalaya ltd.	0.79%	₹ 1.48	Hospitals & Medical Services
STRYKER CORP	0.77%	₹ 1.46	Others
MEDTRONIC PLC	0.71%	₹ 1.35	Others
Global Health Ltd.	0.69%	₹ 1.31	Hospitals & Medical Services
GlaxoSmithKline Pharmaceuticals Ltd.	0.61%	₹ 1.15	Pharmaceuticals
Regeneron Pharmaceuticals Inc	0.46%	₹ 0.87	Others
Anthem Biosciences Ltd.	0.43%	₹ 0.81	Pharmaceuticals
BECTON DICKINSON AND CO	0.31%	₹ 0.58	Others
AGILENT TECHNOLOGIES INC	0.27%	₹ 0.50	Others
WATERS CORP	0.26%	₹ 0.50	Others
IQVIA HOLDINGS INC	0.23%	₹ 0.44	Others
Clearing Corporation of India Ltd.	0.17%	₹ 0.32	Others
Net Receivables/(Payables)	0.05%	₹ 0.09	Others

See All

Returns

	Annualised returns
	9M	1Y	2Y	3Y
Fund returns	-	-	-	-
Category returns	0.53%	2.52%	3.19%	21.25%

Fund Objective

The Scheme will invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the ... Read more

AMC Details

Name

Edelweiss Asset Management Ltd.

Date of Incorporation

30 Apr 2008

CEO

Mrs. Radhika Gupta

CIO

Mr. Dhawal Dalal, Mr. Trideep Bhattacharya

Type

Pvt.Sector-Indian

Address

Edelweiss House, Off. C.S.T Road, Kalina, Mumbai, Maharashtra, India - 400098

Website

http://www.edelweissmf.com

[email protected]

Top Funds from Others - Index Funds/ETFs

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
ICICI Prudential Silver ETF ETF Regular	₹215.96	93.01%	182.63%	0.00%	₹13,864	0.40%	Very High
Aditya Birla Sun Life Silver ETF ETF Regular	₹216.04	92.89%	182.54%	0.00%	₹2,797	0.35%	Very High
Axis Silver ETF ETF Regular	₹215.17	92.54%	182.39%	0.00%	₹1,861	0.42%	Very High
Kotak Silver ETF ETF Regular	₹20.99	92.73%	182.04%	0.00%	₹3,462	0.35%	Very High
DSP Silver ETF ETF Regular	₹208.47	92.78%	181.60%	0.00%	₹1,429	N/A	Very High
Mirae Asset Silver ETF ETF Regular	₹210.70	92.52%	181.51%	0.00%	₹1,132	0.36%	Very High
HDFC Silver ETF ETF Regular	₹207.08	92.14%	181.39%	0.00%	₹7,574	0.50%	Very High
Nippon India Silver ETF ETF Regular	₹206.97	92.34%	180.37%	0.00%	₹30,012	N/A	Very High
UTI Silver Exchange Traded Fund ETF Regular	₹208.97	91.34%	177.61%	0.00%	₹1,326	0.59%	Very High
Mirae Asset NYSE FANG + ETF ETF Regular	₹165.56	31.36%	152.92%	211.58%	₹3,882	0.71%	Very High

Top Funds from Edelweiss Asset Management Ltd.

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
Edelweiss Gold and Silver ETF FoF - Direct Plan Fund of Funds Direct	₹32.04	69.50%	158.45%	0.00%	₹2,889	0.21%	Very High
Edelweiss Gold and Silver ETF FoF - Direct Plan Fund of Funds Direct	₹32.04	69.50%	158.43%	0.00%	₹2,889	0.21%	Very High
Edelweiss Gold and Silver ETF FoF - Direct Plan Fund of Funds Direct	₹32.04	69.50%	158.43%	0.00%	₹2,889	0.21%	Very High
Edelweiss Gold and Silver ETF FoF Fund of Funds Regular	₹31.55	68.87%	155.41%	0.00%	₹2,889	0.56%	Very High
Edelweiss Gold and Silver ETF FoF Fund of Funds Regular	₹31.55	68.87%	155.41%	0.00%	₹2,889	0.56%	Very High
Edelweiss Gold and Silver ETF FoF Fund of Funds Regular	₹31.55	68.87%	155.41%	0.00%	₹2,889	0.56%	Very High
Edelweiss US Technology Equity Fund of Fund - Direct Plan Fund of Funds Direct	₹40.34	32.60%	108.26%	111.63%	₹4,656	0.70%	Very High
Edelweiss US Technology Equity Fund of Fund Fund of Funds Regular	₹37.98	31.45%	102.72%	102.11%	₹4,656	2.32%	Very High
Edelweiss Emerging Markets Opportunities Equity Offshore... International/ Global Direct	₹30.73	63.60%	100.37%	64.53%	₹259	0.56%	Very High
Edelweiss Emerging Markets Opportunities Equity Offshore... International/ Global Regular	₹28.04	62.21%	95.22%	57.43%	₹259	2.29%	Very High

FAQs

What is the fund size (AUM) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan IDCW-Sweep?

The Assets Under Management (AUM) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan IDCW-Sweep is ₹188.90 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.

What are the returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan IDCW-Sweep?

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan IDCW-Sweep was launched on 06 Oct 2020. As this is a relatively new fund, historical return data for standard periods (1Y, 3Y, 5Y) is not yet available. Please check back later for updated performance metrics.

What is the risk level of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan IDCW-Sweep?

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan IDCW-Sweep has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.

What is the minimum investment amount for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan IDCW-Sweep?

The minimum lumpsum investment required for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -Direct Plan IDCW-Sweep is ₹100. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article